CHA News

CHA Raises Concerns Over Board of Pharmacy Proposed Regulations

What’s happening: CHA submitted comments in response to the Board of Pharmacy (BoP) proposed regulations on nonsterile compounding, sterile compounding, and hazardous medications.  

What else to know: In these comments, CHA raises concerns about the regulations’ benefit to patients, the significant financial impact to hospitals, and the lack of evidence that pharmacies are not complying with current state and federal compounding standards.  

CHA believes regulatory guidance provided by the United States Pharmacopeia-National Formulary rules and the BoP’s proposed regulations would have too many unintended consequences without a comprehensive benefit-cost analysis. The analysis would determine whether these regulations will achieve their intended goals without a significant impact on patient care. 

Comments were due to the BoP on June 3.  

The BoP will also hold a public hearing to receive verbal testimony at 9 a.m. on June 18. Additionally, attendees may participate in the hearing via a WebEx meeting platform. To participate through WebEx, contact Lori Martinez at by 4:30 p.m. (PT) on June 17 and request a link to the meeting. Hospitals are encouraged to participate and provide comments. 

For more information, contact Sheree Lowe, vice president, policy, at